相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson et al.
JAMA CARDIOLOGY (2020)
Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
Alan Chait et al.
DIABETES (2020)
Risk Factors for Kidney Disease in Type 1 Diabetes
Bruce A. Perkins et al.
DIABETES CARE (2019)
Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography
Andrew Lin et al.
ATHEROSCLEROSIS (2019)
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study
Monia Garofolo et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J. Vallejo-Vaz et al.
CIRCULATION (2018)
Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes
Valma Harjutsalo et al.
DIABETES OBESITY & METABOLISM (2018)
Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
Osman Ahmed et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Remnant lipoproteins
Anette Varbo et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
Anne-Marie K. Jepsen et al.
CLINICAL CHEMISTRY (2016)
Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes
Gianluca Bardini et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease
Jennifer N. Todd et al.
DIABETES (2015)
Kidney Function, Cholesterol Absorption and Remnant Lipoprotein Accumulation in Patients with Diabetes Mellitus
Mika Sonoda et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals
Mariann I. Lassenius et al.
NUTRITION & METABOLISM (2014)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes
K. Hietala et al.
DIABETOLOGIA (2013)
Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study
N. Tolonen et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients
Y. -H. Chang et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Nonfasting Triglycerides, Cholesterol, and Ischemic Stroke in the General Population
Anette Varbo et al.
ANNALS OF NEUROLOGY (2011)
Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
Ian H. de Boer et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes
Kustaa Hietala et al.
DIABETES CARE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
Johan Waden et al.
DIABETES (2009)
Impaired Postprandial Metabolism of Apolipoprotein B48-Containing Remnant Particles in Normolipidemic Subjects With Brittle Type 1 Diabetes
J. W. Su et al.
DIABETES CARE (2009)
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes
N. Tolonen et al.
DIABETOLOGIA (2009)
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes Data from the Diabetes Control and Complications Trial
Eric S. Kilpatrick et al.
DIABETES CARE (2008)
The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma
K Nakajima et al.
CLINICA CHIMICA ACTA (2006)
Metabolic syndrome in type 1 diabetes -: Association with diabetic nephropathy and glycemic control (the FinnDiane study)
LM Thorn et al.
DIABETES CARE (2005)
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
M Saraheimo et al.
DIABETOLOGIA (2003)
Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy
AJ Jenkins et al.
KIDNEY INTERNATIONAL (2003)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells
EG Lynn et al.
KIDNEY INTERNATIONAL (2000)
分享论文
